What is Clover Health Investments Enterprise Value?
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Clover Health Investments's Enterprise Value is €121 Mil.
Clover Health Investments's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €-151 Mil. Therefore, Clover Health Investments's EV-to-EBIT ratio for today is -0.81.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Clover Health Investments's Enterprise Value
For the Healthcare Plans subindustry, Clover Health Investments's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clover Health Investments's Enterprise Value Distribution in the Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Clover Health Investments's Enterprise Value falls into.
Clover Health Investments Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Clover Health Investments's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clover Health Investments (STU:7QD) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Clover Health Investments's EV-to-EBIT for today is
Clover Health Investments's current Enterprise Value is €121 Mil.
Clover Health Investments's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-151 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Clover Health Investments's EV-to-EBITDA for today is:
Clover Health Investments's current Enterprise Value is €121 Mil.
Clover Health Investments's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-148 Mil.
Clover Health Investments's current Enterprise Value is €121 Mil.
Clover Health Investments's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,713 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clover Health Investments Enterprise Value Related Terms
Thank you for viewing the detailed overview of Clover Health Investments's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Clover Health Investments (STU:7QD) Business Description
Clover Health Investments Corp is a healthcare technology company. It uses its proprietary technology platform to collect, structure, & analyze health & behavioral data to improve medical outcomes & lower costs for patients. The Group has two operating segments. The insurance segment provides PPO(Preferred provider Organization) & HMO(Health Maintenance Organization) plans to Medicare Advantage members in several states & seeks to improve care & lower costs which generally provide access to a wide network of primary care providers, specialists, & hospitals. Non-insurance segment includes the Company's operations relating to CMS' DC (Direct Contracting) Model, which provides options aimed at reducing expenditures & preserving or enhancing the quality of care for beneficiaries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:7QD has been successfully added to your 